A proposed testing framework for developmental immunotoxicology (DIT)

Toxicological Sciences

Volumn 83, Issue 1, 2005, Pages 18-24

  Holsapple, Michael P ^a   Burns Naas, Leigh Ann ^b   Hastings, Kenneth L ^c   Ladics, Gregory S ^d   Lavin, Amy L ^a   Makris, Susan L ^e   Yang, Yung ^e   Luster, Michael I ^f  

^a International Life Sciences Institute   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d DUPONT COMPANY   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Developmental and reproductive toxicology; Developmental immunotoxicology; DIT; Immune system; Risk assessment; Roundtable; Study design; Testing methods

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; DEVELOPMENTAL DISORDER; DRUG EXPOSURE; DRUG USE; EUROPEAN UNION; HUMAN; IMMUNOASSAY; IMMUNOTOXICITY; MEDICAL EXPERT; METHODOLOGY; NONHUMAN; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STRUCTURE ACTIVITY RELATION; UNITED STATES; VALIDATION PROCESS;

ANIMALS; REPRODUCTION; RESEARCH DESIGN; RISK ASSESSMENT; TOXICITY TESTS;

ANIMALIA;

EID: 12344331457     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh299     Document Type: Article

References (35)

1. Barnett, J. B. (1996). Developmental immunotoxicology. In Experimental Immunotoxicology (R. J. Smialowicz and M. P. Holsapple, Eds.), pp. 47-62. CRC Press, Boca Raton, FL.
2. Bunn, T. L., Ladics, G. S., Holsapple, M. P., and Dietert, R. R. (2001a). Developmental immunotoxicity assessment in the rat: Age, gender, and strain comparisons after exposure to lead. Toxicol. Methods 11, 41-58.
3. Bunn, T. L., Parsons, P. J., Kao, E., and Dietert, R. R. (2001b). Exposure to lead during critical windows of embryonic development: Differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 64, 57-66.
4. Dietert, R. R. (2003). Developmental immunotoxicology: Overview of issues including critical windows of development. Reproduct. Toxicol. 17, 478-479.
5. Dietert, R. R., Etzel, R. A., Chen, D., Halonen, M., Holladay, S. D., Jarabek, A. M., Landreth, K., Peden, D. B., Pinkerton, K., Smialowicz, R. J., and Zoetis, T. (2000). Workshop to identify critical windows of exposure for children's health: Immune and respiratory systems work group summary. Environ. Health Perspect. 108(Suppl. 3), 483-490.
6. Dietert, R. R. and Lee, J. (2003). Susceptibility of the developing immune system to immunosuppressive agents: Differential risk across life stages. Toxicologist 72(S-1), 225.
7. Dietert, R. R., Lee, J. E., and Bunn, T. L. (2001). Developmental immunotoxicology: Emerging issues. Human Exp. Toxicol. 21, 479-485.
8. Dietert, R. R., Lee, J.-E., Olsen, J., Fitch, K., and Marsh, J. A. (2003). Developmental immunotoxicity of dexamethasone: Comparison of fetal vs. adult exposures. Toxicology 194, 163-176.
9. Dietert, R. R., Lee, J.-E., Olsen, J., Fitch, K., and Marsh, J. A. (2004). Dexamethasone-induced immunotoxicity following fetal vs. adult exposure. Toxicologist 78(S-1), 96.
10. Gehrs, B. C., and Smialowicz, R. J. (1999). Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Toxicology 134, 79-88.
11. Germolec, D. R., Nyska, A., Kashon, M., Kuper, C. F., Portier, C., Kommineni, C., Johnson, K. A., and Luster, M. I. (2004). Extended histopathology in immunotoxicity testing: Interlaboratory validation studies. Toxicol. Sci. 78, 107-115.
12. Guo, T. L., White, Jr., K. L., Brown, R. D., Delclos, K. B., Newbold, R. R., Weis, C., Germolec, D. R., and McKay, J. A. (2002). Genestein modulates splenic natural killer cell activity, antibody-forming cell responses and phenotypic marker expression in F0 and F1 generations of Sprague Dawley rats. Toxicol. Appl. Pharmacol. 181, 219-227.
13. Holsapple, M. P. (1995). The plaque-forming cell (PFC) response in immunotoxicology: An approach to monitoring the primary effect function of B lymphocytes. In Methods in Immuntoxicology, Vol. 1 (G. R. Burleson, J. H. Dean, and A. E. Munson, Eds.), pp. 150-76. Wiley-Liss, New York.
14. Holsapple, M. P. (2002). Developmental immunotoxicology and risk assessment: A workshop summary. Human Exp. Toxicol. 21, 473-478.
15. Holsapple, M. P., West, L. J., and Landreth, K. S. (2003). Species comparison of anatomical and functional immune system development. Birth Defects Res. 68, 321-334.
16. International Conference on Harmonisation. (1998). ICH-S5A, Guideline for Industry, Detection of Toxicity to Reproduction for Medicinal Products.
17. Karrow, N. A., Guo, T. L., Delclos, K. B., Newbold, R. R., Weis, C., Germolec, D. R., White, Jr., K. L., and McKay, J. A. (2004). Nonylphenol alters the activity of splenic NK cells and the numbers of leukocytes subpopulations in Sprague-Dawley rats: A two generation feeding study. Toxicology. 196, 237-245.
18. Ladics, G. S., Smith, C., Bunn, T. L., Dietert, R. R., Anderson, P. K., Wiescinski, C. M., and Holsapple, M. P. (2000). Characterization of an approach to developmental immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol. Methods 10, 283-311.
19. Landreth, K. S. (2002). Critical windows in development of the rodent immune system. Human Exp. Toxicol. 21, 493-498.
20. Luster, M. I., Munson, A. E., Thomas, P. T., Holsapple, M. P., Fenters, J. D., White, K. L., Jr., Lauer, L. D., Germolec, D. R., Rosenthal, G. J., and Dean, J. H. (1988). Development of a testing battery to assess chemical induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 1, 2-19.
21. Luster, M. I., Portier, C., Pait, D. G., White, K. L., Jr., Gennings, C., Munson, A. E., and Rosenthal, G. J. (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18, 200-210.
22. Luster, M. I., Portier, C., Pait, D. G., Rosenthal, G. J., Germolec, D. R., Corsini, E., Blaylock, B. L., Pollock, P., Kouchi, Y., Craig, W., White, K. L., Munson, A. E., and Comment, C. E. (1993). Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21, 71-82.
23. Luster, M. I., Dean, J. H., and Germolec, D. R. (2003). Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111, 579-583.
24. Matulka, R. A. Rooney, A. A., Williams, W., Copeland, C. B., and Smialowicz, R. J. (2003). Perinatal exposure to the pesticide heptachlor produces alterations in immune function parameters in Sprague-Dawley rats. Toxicologist 72(S-1), 830.
25. Miller, T. E., Golemboski, K. A., Ha, H. A., Bunn, T. L., Sanders, F. S., and Dietert, R. R. (1998). Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci. 42, 129-135.
26. Morris, J. G., Jr., and Potter, M. (1997). Emergence of new pathogens as a function of changes in host susceptibility. Emerg. Infect. Dis. 3, 433-441.
27. Smialowicz, R. J, Williams, W. C., Copeland, C. B., Harris, C. W., Overstreet, D., Davis, B. J., and Chapin, R. E. (2001). The effects of perinatal/juvenile heptachlor exposure on adult immune and reproductive function in rats. Toxicol. Sci. 61, 164-75.
28. Temple, L., Kawabata, T. T., Munson, A. E., and White, K. L., Jr. (1993). Comparison of ELISA and plaque-forming cell assays for measuring the Immoral immune response to SRBC in rats and mice treated with benzo(a)pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21, 412-419.
29. U.S. Environmental Protection Agency. (1991). Guidelines for developmental toxicity risk assessment. Federal Register 56:63798-63826.
30. U.S. Environmental Protection Agency. (1998a). OPPTS 870.3700, Prenatal Developmental Toxicity Study, Health Effects Test Guidelines, EPA 712-C-98-207, Washington, DC.
31. U.S. Environmental Protection Agency. (1998b). OPPTS 870.3800, Reproduction and Fertility Effects, Health Effects Test Guidelines, EPA 712-C-98-208, Washington, DC.
32. U.S. Environmental Protection Agency. (1998c). OPPTS 870.6300, Developmental Neurotoxicity Study, Health Effects Test Guidelines, EPA 712-C98-239, Washington, DC.
33. U.S. Environmental Protection Agency. (1998d). OPPTS 870.7800, Immunotoxicity, Health Effects Test Guidelines, EPA 712-C98-351, Washington, DC.
34. U.S. Food and Drug Administration. (2002). Center for Drug Evaluation and Research. Guidance for Industry. Immunotoxicology Evaluation of Investigational New Drugs.
35. U.S. Food and Drug Administration. (2004). Center for Drug Evaluation and Research. Guidance for Industry. Nonclinical Safety Evaluation of Pediatric Drug Product.